Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Immune-related colitis – an issue in cancer patients

By Mindo - 20th Dec 2021 | 107 views

The photo of large intestine is on the man's body against gray background, People With Stomach ache problem concept, Male anatomy

Irish Society of Gastroenterology, Winter Meeting, virtual, 2-3 December 2021

While immunotherapy has been a game changer in many different types of cancer, it comes at a cost of increased risk of immune-related complications in other organ systems, such as immunotherapy-induced colitis, the Irish Society of Gastroenterology 2021 Winter Meeting heard.

Dr Nick Powell, Consultant Gastroenterologist and Clinical Reader in Gastroenterology Imperial College London, said this is a growing issue that needs to be appropriately managed to ensure cancer patients achieve optimum outcomes and quality-of-life.

It is well known that chemotherapy causes diarrhoea and radiotherapy can cause pelvic area complications (proctitis, enteritis, etc) in cancer patients but newer agents, such as immune checkpoint inhibitors (CPI), are also causing issues, according to Dr Powell, who runs a special clinic with his oncology colleagues for these patients.

He quoted research showing the implications of CPI-related colitis development as being the most common reason for hospitalisation, treatment discontinuation, and treatment-related death (usually colonic perforation, in up to 5 per cent of these patients).

In relation to grading the severity of CPI-induced diarrhoea, Dr Powell discussed using the National Cancer Institute’s ‘common terminology criteria for adverse events’ scoring system, which has five grades of severity, noting that it has
no correlation with mucosal injury.

In terms of treatment and investigation, the British Society of Gastroenterology published new guidance last year, which was developed by a multidisciplinary group of gastroenterologists, oncologists, histopathologists, specialist nurses, dietitians, and patients. The US has also recently published guidance.

“In terms of investigation I think it is very important to achieve tissue diagnosis, to make sure we are treating the right
problem,” Dr Powell said.

Leave a Reply

Latest
Latest Issue
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read